skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 572  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology
Material Type:
Article
Add to My Research

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

European heart journal, 2018-12, Vol.39 (48), p.4243-4254 [Peer Reviewed Journal]

Attribution - NonCommercial ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. 2018 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy596 ;PMID: 30295797

Full text available

2
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Material Type:
Article
Add to My Research

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

The Lancet (British edition), 2015-05, Vol.385 (9982), p.2107-2117 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 23, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61402-1 ;PMID: 26009231 ;CODEN: LANCAO

Full text available

3
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
Material Type:
Article
Add to My Research

Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes

Neurology, 2017-10, Vol.89 (18), p.1877-1885 [Peer Reviewed Journal]

2017 American Academy of Neurology ;2017 American Academy of Neurology. ;2017 American Academy of Neurology 2017 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000004586 ;PMID: 28954880

Full text available

4
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Material Type:
Article
Add to My Research

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

The Lancet (British edition), 2013-09, Vol.382 (9896), p.941-950 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 14, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60683-2 ;PMID: 23850055 ;CODEN: LANCAO

Full text available

5
Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia
Material Type:
Article
Add to My Research

Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia

Endocrine reviews, 2019-06, Vol.40 (3), p.768-788 [Peer Reviewed Journal]

Copyright © 2019 Endocrine Society 2019 ;Copyright © Oxford University Press 2015 ;Copyright © 2019 Endocrine Society. ;COPYRIGHT 2019 Oxford University Press ;Copyright © 2019 Endocrine Society ;ISSN: 0163-769X ;EISSN: 1945-7189 ;DOI: 10.1210/er.2018-00226 ;PMID: 30689785

Full text available

6
Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes
Material Type:
Article
Add to My Research

Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes

The New England journal of medicine, 2013-07, Vol.369 (4), p.362-372 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1215228 ;PMID: 23883381 ;CODEN: NEJMAG

Full text available

7
Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies
Material Type:
Article
Add to My Research

Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies

Diabetes care, 2017-05, Vol.40 (5), p.706-714 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association May 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-1943 ;PMID: 28428321

Full text available

8
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
Material Type:
Article
Add to My Research

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

Diabetes care, 2018-08, Vol.41 (8), p.1543-1556 [Peer Reviewed Journal]

2018 by the American Diabetes Association. ;Copyright American Diabetes Association Aug 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc18-0588 ;PMID: 30030256

Full text available

9
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
Material Type:
Article
Add to My Research

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls

Diabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1165-1173

2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12354 ;PMID: 25041462 ;CODEN: DOMEF6

Full text available

10
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
Material Type:
Article
Add to My Research

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

BMJ (Online), 2018-07, Vol.362, p.k2693 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k2693 ;PMID: 30021781

Full text available

11
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
Material Type:
Article
Add to My Research

Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes

The New England journal of medicine, 2022-09, Vol.387 (12), p.1063-1074 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2200433 ;PMID: 36129996

Full text available

12
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases
Material Type:
Article
Add to My Research

Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases

Diabetes care, 2020-11, Vol.43 (11), p.2859-2869 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Nov 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1890 ;PMID: 32938746

Full text available

13
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Material Type:
Article
Add to My Research

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

The New England journal of medicine, 2022-09, Vol.387 (12), p.1075-1088 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2200436 ;PMID: 36129997

Full text available

14
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy
Material Type:
Article
Add to My Research

Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy

Circulation (New York, N.Y.), 2021-02, Vol.143 (8), p.770-779 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.047965 ;PMID: 33302723

Full text available

15
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐Analysis
Material Type:
Article
Add to My Research

Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐Analysis

The oncologist (Dayton, Ohio), 2012, Vol.17 (6), p.813-822 [Peer Reviewed Journal]

2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2011-0462 ;PMID: 22643536

Full text available

16
The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials
Material Type:
Article
Add to My Research

The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials

PLoS medicine, 2016-04, Vol.13 (4), p.e1001992-e1001992 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Varvaki Rados D, Catani Pinto L, Reck Remonti L, Bauermann Leitão C, Gross JL (2016) The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials. PLoS Med 13(4): e1001992. doi:10.1371/journal.pmed.1001992 ;2016 Varvaki Rados et al 2016 Varvaki Rados et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Varvaki Rados D, Catani Pinto L, Reck Remonti L, Bauermann Leitão C, Gross JL (2016) The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials. PLoS Med 13(4): e1001992. doi:10.1371/journal.pmed.1001992 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001992 ;PMID: 27071029

Full text available

17
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

Diabetes/metabolism research and reviews, 2012-02, Vol.28 (2), p.109-122 [Peer Reviewed Journal]

Copyright © 2011 John Wiley & Sons, Ltd. ;ISSN: 1520-7552 ;EISSN: 1520-7560 ;DOI: 10.1002/dmrr.1291 ;PMID: 21898753

Full text available

18
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials
Material Type:
Article
Add to My Research

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials

PLoS medicine, 2012-04, Vol.9 (4), p.e1001204 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Boussageon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, et al. (2012) Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials. PLoS Med 9(4): e1001204. doi:10.1371/journal.pmed.1001204 ;Distributed under a Creative Commons Attribution 4.0 International License ;Boussageon et al. 2012 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001204 ;PMID: 22509138

Full text available

19
Diabetes and Cancer: A Consensus Report
Material Type:
Article
Add to My Research

Diabetes and Cancer: A Consensus Report

CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.207-221 [Peer Reviewed Journal]

Copyright © 2010 American Cancer Society, Inc. ;(c) 2010 American Cancer Society, Inc. ;Copyright Lippincott Williams & Wilkins Jul/Aug 2010 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.20078 ;PMID: 20554718 ;CODEN: CAMCAM

Full text available

20
Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis

The American journal of gastroenterology, 2013-04, Vol.108 (4), p.510-519 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 2013 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2013.7 ;PMID: 23399556

Full text available

Results 1 - 20 of 572  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (513)

Refine My Results

Creation Date 

From To
  1. Before 1983  (29)
  2. 1983 To 1993  (29)
  3. 1994 To 2003  (107)
  4. 2004 To 2014  (206)
  5. After 2014  (201)
  6. More options open sub menu

Resource Type 

  1. Articles  (570)
  2. Web Resources  (2)
  3. More options open sub menu

Language 

  1. English  (553)
  2. Japanese  (64)
  3. French  (12)
  4. Spanish  (3)
  5. Russian  (2)
  6. Norwegian  (2)
  7. Portuguese  (1)
  8. German  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait